Pre-Clinical Imaging (In-VIVO) Market is Expected to Reach $797 Million by 2019
Advancements in molecular imaging technologies, growing acceptance of pre-clinical imaging as a legitimate drug development tool, and increasing demand for multi-modality imaging technologies in pre-clinical research are key factors fuelling the growth of the market.
North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas 7, February 13, 2015 (Newswire.com) - The report “Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019”.
Full Report Deatisl @ www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market-841.html
Major Players are LI-COR Biosciences (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd (U.K.), TriFoil Imaging (U.S.), and FUJIFILM VisualSonics, Inc. (Canada)
Marketsandmarkets
Early buyers will receive 10% customization on reports.
This report studies the global preclinical imaging market over the forecast period of 2014 to 2019. The market is expected to reach $797 million by 2019, at CAGR of 6.0% from 2014 to 2019.
The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
For Report Inquiry @
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=841
Based on modality, the global preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and trimodality (PET/SPECT/CT) imaging systems.
Bases on the reagents, the global preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further subsegmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.
A number of factors such as technological advancements in molecular imaging modalities, rising adoption of multi-modality imaging systems in preclinical research studies, and growing acceptance of preclinical imaging in drug discovery and development processes are fuelling the demand of preclinical imaging systems and reagents. On the other hand, declining NIH budgets for medical science research studies and high implementation cost of sophisticated preclinical imaging systems are restricting the growth of the global preclinical imaging market.
As of 2014, North America holds the largest share of the global preclinical imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2014 to 2019. A number of factors, including rising R&D activities by big pharma and biotech companies in developing nations, increased government funding for development of pharmaceutical industry, and growing number of CROs in emerging markets are stimulating the growth of the preclinical imaging market in the Asia-Pacific region. However, challenges associated with the application of radioisotopes, such as short half-life of PET radioisotopes and high cost involved in the generation of these isotopes, restricts the demand for micro-PET systems in developing Asian countries.
Aspect Imaging (Israel), Biospace Lab S.A. (France), Bruker Corporation (U.S.), LI-COR Biosciences (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd (U.K.), PerkinElmer, Inc. (U.S.), TriFoil Imaging (U.S.), and FUJIFILM VisualSonics, Inc. (Canada) are the key players operating in the global preclinical imaging systems and reagents market.
Click Here to get Healthcare Research Report Subscription